Reviva Pharmaceuticals Correlations

RVPH Stock

USD 1.49 0.04 2.76%

The current 90-days correlation between Reviva Pharmaceuticals and Ideaya Biosciences is 0.11 (i.e., Average diversification). The correlation of Reviva Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Reviva Pharmaceuticals Correlation With Market

Good diversification

The correlation between Reviva Pharmaceuticals Holding and NYA is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and NYA in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Moving together with Reviva Stock

0.77	BKRKF	PT Bank Rakyat	Pair Corr
0.77	BKRKY	Bank Rakyat	Pair Corr
0.77	PPERY	Bank Mandiri Persero	Pair Corr
0.71	PPERF	Bank Mandiri Persero	Pair Corr
0.72	PBCRY	Bank Central Asia	Pair Corr
0.62	TRV	The Travelers Companies Financial Report 18th of July 2024	Pair Corr
0.67	INTC	Intel Aggressive Push	Pair Corr
0.61	MCD	McDonalds Financial Report 25th of July 2024	Pair Corr
0.68	IBM	International Business Financial Report 17th of July 2024	Pair Corr
0.66	CSCO	Cisco Systems Sell-off Trend	Pair Corr

Moving against Reviva Stock

0.92	JPSTF	JAPAN POST BANK	Pair Corr
0.81	JPHLF	Japan Post Holdings	Pair Corr
0.76	HPQ	HP Inc Fiscal Year End 19th of November 2024	Pair Corr
0.58	MZHOF	Mizuho Financial	Pair Corr
0.35	MRK	Merck Company Financial Report 6th of August 2024	Pair Corr
0.8	KO	Coca Cola Sell-off Trend	Pair Corr
0.8	PG	Procter Gamble Financial Report 26th of July 2024	Pair Corr
0.75	PFE	Pfizer Inc Sell-off Trend	Pair Corr
0.75	DD	Dupont De Nemours Financial Report 7th of August 2024	Pair Corr
0.71	AXP	American Express Financial Report 19th of July 2024	Pair Corr
0.68	T	ATT Inc Earnings Call Tomorrow	Pair Corr
0.55	GE	GE Aerospace Financial Report 23rd of July 2024	Pair Corr
0.55	JPM	JPMorgan Chase Financial Report 12th of July 2024	Pair Corr
0.34	MSFT	Microsoft Aggressive Push	Pair Corr

Related Correlations Analysis

	IDYA	ANAB	MGTX	KROS	TNYA	IGMS	GLUE	MRUS	INBX
IDYA		0.21	0.8	0.84	0.73	0.63	0.71	-0.41	0.6	IDYA
ANAB	0.21		0.05	-0.18	0.04	0.5	-0.35	0.38	-0.13	ANAB
MGTX	0.8	0.05		0.77	0.74	0.54	0.7	-0.29	0.48	MGTX
KROS	0.84	-0.18	0.77		0.81	0.43	0.89	-0.52	0.66	KROS
TNYA	0.73	0.04	0.74	0.81		0.63	0.63	-0.34	0.62	TNYA
IGMS	0.63	0.5	0.54	0.43	0.63		0.21	0.01	0.36	IGMS
GLUE	0.71	-0.35	0.7	0.89	0.63	0.21		-0.57	0.62	GLUE
MRUS	-0.41	0.38	-0.29	-0.52	-0.34	0.01	-0.57		-0.73	MRUS
INBX	0.6	-0.13	0.48	0.66	0.62	0.36	0.62	-0.73		INBX
	IDYA	ANAB	MGTX	KROS	TNYA	IGMS	GLUE	MRUS	INBX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GLUE	+ 0.89	KROS
KROS	+ 0.84	IDYA
TNYA	+ 0.81	KROS
MGTX	+ 0.8	IDYA
KROS	+ 0.77	MGTX
TNYA	+ 0.74	MGTX

High negative correlations

INBX	- 0.73	MRUS
MRUS	- 0.57	GLUE
MRUS	- 0.52	KROS
MRUS	- 0.41	IDYA
GLUE	- 0.35	ANAB
MRUS	- 0.34	TNYA

Risk-Adjusted Indicators

There is a big difference between Reviva Stock performing well and Reviva Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Reviva Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
IDYA	2.06	(0.26)	0.00	(0.12)	0.00	0.00	2.74	(4.35)	10.88
ANAB	3.27	0.03	0.01	0.04	4.43	(3.31)	11.29	(7.64)	25.02
MGTX	2.33	(0.38)	0.00	(0.26)	0.00	0.00	4.61	(4.82)	16.81
KROS	2.24	(0.55)	0.00	(0.35)	0.00	0.00	3.89	(5.18)	12.55
TNYA	3.23	(0.73)	0.00	(0.30)	0.00	0.00	5.74	(8.80)	18.46
IGMS	4.68	(0.41)	0.00	(0.58)	0.00	0.00	9.57	(11.63)	48.77
GLUE	4.05	(0.42)	0.00	(0.16)	0.00	0.00	7.66	(8.78)	31.83
MRUS	2.70	0.42	0.15	0.46	2.51	(3.17)	6.11	(4.18)	44.66
INBX	2.11	(0.63)	0.00	(0.21)	0.00	0.00	2.46	(1.86)	60.40

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC